Gene expression profiling analysis reveals that the long non‑coding RNA uc.412 is involved in mesangial cell proliferation

Yu,Minyi; Guan,Zheng; Li,Shanwen; Wen,Xianli; Shi,Huimin; Qu,Gaoting; Lu,Xiaoyu; Zhu,Xianyi; Wang,Bin; Feng,Qihua; Gan,Weihua; Zhang,Aiqing

doi:10.3892/mmr.2019.10753

Gene expression profiling analysis reveals that the long non‑coding RNA uc.412 is involved in mesangial cell proliferation

Authors:
- Minyi Yu
- Zheng Guan
- Shanwen Li
- Xianli Wen
- Huimin Shi
- Gaoting Qu
- Xiaoyu Lu
- Xianyi Zhu
- Bin Wang
- Qihua Feng
- Weihua Gan
- Aiqing Zhang
View Affiliations

Affiliations: Department of Pediatric Nephrology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210003, P.R. China, Institute of Nephrology, Zhong Da Hospital, Southeast University, Nanjing, Jiangsu 210000, P.R. China, Department of Rheumatology, Children's Hospital of Soochow University, Suzhou, Jiangsu 215000, P.R. China
Published online on: October 16, 2019 https://doi.org/10.3892/mmr.2019.10753
Pages: 5297-5303
Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hyperproliferation of mesangial cells (MCs) is the central pathological feature observed in certain human renal diseases. Furthermore, the long non‑coding RNA uc.412 is regulated by transforming growth factor β1 in mesangial cells in vitro. The present study aimed to investigate whether uc.412 serves a role in renal fibrosis and whether it may be considered as a therapeutic target in mesangial proliferative kidney diseases. The results demonstrated that uc.412 overexpression significantly increased MC proliferation. The transcriptional profile of MCs overexpressing uc.412 was assessed by RNA sequencing. A total of 462 up‑ and 843 downregulated genes were identified (|fold change| ≥1.5), and reverse transcription‑quantitative PCR was used to determine the expression of these differentially expressed genes (DEGs). Subsequently, the potential function of these DEGs was determined by bioinformatics analyses. The results indicated that these DEGs were involved in numerous signaling pathways associated with MC proliferation. The downstream association between up‑ and downregulated genes was constructed via the STRING database. The protein‑protein interaction network indicated that serpin family E member 1 and matrix metallopeptidase 3 may be hub proteins. In conclusion, the present study provided novel insight into the role of uc.412 in MC proliferation, which may aid in the development of novel treatment for mesangial proliferative kidney diseases.

View Figures

View References

1	Cove-Smith A and Hendry BM: The regulation of mesangial cell proliferation. Nephron Exp Nephrol. 108:e74–e79. 2008. View Article : Google Scholar : PubMed/NCBI
2	Kurogi Y: Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Med Res Rev. 23:15–31. 2003. View Article : Google Scholar : PubMed/NCBI
3	Zhang A, Han Y, Wang B, Li S and Gan W: Beyond gap Junction channel function: The expression of Cx43 contributes to aldosterone-induced mesangial cell proliferation via the ERK1/2 and PKC pathways. Cell Physiol Biochem. 36:1210–1222. 2015. View Article : Google Scholar : PubMed/NCBI
4	Loeffler I and Wolf G: Transforming growth factor-β and the progression of renal disease. Nephrol Dial Transplant. 29 (Suppl 1):i37–i45. 2014. View Article : Google Scholar : PubMed/NCBI
5	Rodrigues-Diez R, Rayego-Mateos S, Orejudo M, Aroeira LS, Selgas R, Ortiz A, Egido J and Ruiz-Ortega M: TGF-beta blockade increases renal inflammation caused by the C-terminal module of the CCN2. Mediators Inflamm. 2015:5060412015. View Article : Google Scholar : PubMed/NCBI
6	Kopp F and Mendell JT: Functional classification and experimental dissection of long noncoding RNAs. Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI
7	Tang PM, Tang PC, Chung JY and Lan HY: TGF-β1 signaling in kidney disease: From Smads to long non-coding RNAs. Noncoding RNA Res. 2:68–73. 2017. View Article : Google Scholar : PubMed/NCBI
8	Tang W, Zhang D and Ma X: RNA-sequencing reveals genome-wide long non-coding RNAs profiling associated with early development of diabetic nephropathy. Oncotarget. 8:105832–105847. 2017. View Article : Google Scholar : PubMed/NCBI
9	Bai X, Geng J, Li X, Wan J, Liu J, Zhou Z and Liu X: Long noncoding RNA LINC01619 regulates MicroRNA-27a/Forkhead box protein O1 and endoplasmic reticulum stress-mediated podocyte injury in diabetic nephropathy. Antioxid Redox Signal. 29:355–376. 2018. View Article : Google Scholar : PubMed/NCBI
10	Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y, Chen W, Liu F, Sun W, Li XF, et al: Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 29:653–668. 2016. View Article : Google Scholar : PubMed/NCBI
11	Zhang A, He Y, Wang B, Shi H and Gan W: Analysis of the differential expression of long noncoding RNAs in experimental mesangial cells proliferation induced by TGF-β. Chin J Nephrol. 31:774–779. 2015.
12	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
13	Ma F, Fuqua BK, Hasin Y, Yukhtman C, Vulpe CD, Lusis AJ and Pellegrini M: A comparison between whole transcript and 3′RNA sequencing methods using Kapa and Lexogen library preparation methods. BMC Genomics. 20:92019. View Article : Google Scholar : PubMed/NCBI
14	Huang da W, Sherman BT and Lempicki RA: Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
15	Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2008. View Article : Google Scholar
16	Cui Y, Huang Y, Wu X, Zheng M, Xia Y, Fu Z, Ge H, Wang S and Xie H: Hypoxia-induced tRNA-derived fragments, novel regulatory factor for doxorubicin resistance in triple-negative breast cancer. J Cell Physiol. 234:8740–8751. 2019. View Article : Google Scholar : PubMed/NCBI
17	Zhai W, Sun Y, Jiang M, Wang M, Gasiewicz TA, Zheng J and Chang C: Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia. Oncogene. 35:4866–4880. 2016. View Article : Google Scholar : PubMed/NCBI
18	Dong T, Peng Y, Zhong N, Liu F, Zhang H, Xu M, Liu R, Han M, Tian X, Jia J, et al: Perfluorodecanoic acid (PFDA) promotes gastric cell proliferation via sPLA2-IIA. Oncotarget. 8:50911–50920. 2017.PubMed/NCBI
19	Kawakami T, Ren S and Duffield JS: Wnt signalling in kidney diseases: Dual roles in renal injury and repair. J Pathol. 229:221–231. 2013. View Article : Google Scholar : PubMed/NCBI
20	Ying Q and Wu G: Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: An update. Ren Fail. 39:474–483. 2017. View Article : Google Scholar : PubMed/NCBI
21	Lan T, Wu T, Chen C, Chen X, Hao J, Huang J, Wang L and Huang H: Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells: Involvement of suppression of cell cycle progression and NF-κB/AP-1 pathways. Mol Cell Endocrinol. 384:109–116. 2014. View Article : Google Scholar : PubMed/NCBI
22	Chen D, Li Y, Mei Y, Geng W, Yang J, Hong Q, Feng Z, Cai G, Zhu H, Shi S, et al: miR-34a regulates mesangial cell proliferation via the PDGFR-β/Ras-MAPK signaling pathway. Cell Mol Life Sci. 71:4027–4042. 2014. View Article : Google Scholar : PubMed/NCBI
23	Zhou X, Workeneh B, Hu Z and Li R: Effect of immunosuppression on the human mesangial cell cycle. Mol Med Rep. 11:910–916. 2015. View Article : Google Scholar : PubMed/NCBI
24	Tian J, Wang Y, Liu X, Zhou X and Li R: Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms. Exp Biol Med (Maywood). 240:936–945. 2015. View Article : Google Scholar : PubMed/NCBI
25	Lu Y, Wen J, Chen D, Wu L, Li Q, Xie Y, Wu D, Liu X and Chen X: Modulation of cyclins and p53 in mesangial cell proliferation and apoptosis during Habu nephritis. Clin Exp Nephrol. 20:178–186. 2016. View Article : Google Scholar : PubMed/NCBI
26	Liu L, Gao C, Chen G, Li X, Li J, Wan Q and Xu Y: Notch signaling molecules activate TGF-β in rat mesangial cells under high glucose conditions. J Diabetes Res. 2013:9797022013. View Article : Google Scholar : PubMed/NCBI
27	Toda N, Mukoyama M, Yanagita M and Yokoi H: CTGF in kidney fibrosis and glomerulonephritis. Inflamm Regen. 38:142018. View Article : Google Scholar : PubMed/NCBI
28	Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J and Narins RG: Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol. 11:25–38. 2000.PubMed/NCBI
29	Zhao WX, Zhuang X, Huang TT, Feng R and Lin JH: Effects of Notch2 and Notch3 on cell proliferation and apoptosis of trophoblast cell lines. Int J Med Sci. 12:867–874. 2015. View Article : Google Scholar : PubMed/NCBI